Moleculin to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
- Friday, September 17, 2021, 7:16
- PR Newswire
- Add a comment
HOUSTON, Sept. 17, 2021 /PRNewswire/ — Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that Walter Klemp, President and…
About the Author
admin has written 20982 stories on this site.